IDEXX Laboratories, Inc. Revenue for the Trailing 12 Months (TTM) ending March 31, 2025: USD 3.93 B

IDEXX Laboratories, Inc. Revenue is USD 3.93 B for the Trailing 12 Months (TTM) ending March 31, 2025, a 5.56% change year over year. Revenue is the total amount of money generated from the sales of goods or services by a company during a specific period.
  • IDEXX Laboratories, Inc. Revenue for the Trailing 12 Months (TTM) ending March 31, 2024 was USD 3.72 B, a 8.57% change year over year.
  • IDEXX Laboratories, Inc. Revenue for the Trailing 12 Months (TTM) ending March 31, 2023 was USD 3.43 B, a 4.79% change year over year.
  • IDEXX Laboratories, Inc. Revenue for the Trailing 12 Months (TTM) ending March 31, 2022 was USD 3.27 B, a 14.56% change year over year.
  • IDEXX Laboratories, Inc. Revenue for the Trailing 12 Months (TTM) ending March 31, 2021 was USD 2.86 B, a 16.31% change year over year.
Key Data
Date Revenue Revenue Gross Profit Operating Income